ABSTRACT
Background: India has the highest burden of tuberculosis in the world. It is experiencing an increasing burden of noncommunicable diseases, thereby facing a dual disease burden. Recent evidence shows an association between TB and noncommunicable diseases like diabetes, CVD and chronic respiratory infections. Aims and Objectives: To assess the feasibility of screening for NCDs and risk factors for NCDs among patients with TB in DOTS centers of a medical college in Delhi and ascertain challenges for the same among providers and patients. Methodology: It was a mixed-methods study with a quantitative component (cross-sectional study using questionnaires, anthropometric measurements and records review) and a qualitative component (descriptive study using interview data). Results: Among the 139 patients screened, ten new cases of hypertension and six new patients were diagnosed with DM. Outof- pocket expenditure for tests was a concern of the patients. Health care providers found the screening tool easy to use but were apprehensive about increased workload Conclusion: The study provide useful visions for incorporating NCDs into routine TB care through DOTS centers under RNTCP/NTEP.
ABSTRACT
Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication. Tuberculosis is responsible for the death of every third AIDS patient in India and accounts for about a quarter of the global tuberculosis burden. The ministry reiterated their commitment to eliminating tuberculosis in the country by 2025. This article gives dentists an overview of the guidelines' recommendations that are applicable to most outpatient dental settings.
ABSTRACT
Background: India is having 27% of the world’s drug resistant TB burden. To address this emerging public health concern PMDT services were rolled out in the year 2007 and the nationwide coverage was achieved in the year 2013. In India, MDR RR TB patients started on se cond - line treatment in the years 2018 and 2020 under PMDT had favorable treatment outcomes of 56% and 57% respectively. Therefore, th is study was conducted to determine the treatment outcomes in patients of DR TB & MDR RR TB in Bengaluru city Karnataka, In dia. Methods: This was a descriptive cross - sectional study using programmatic data among the notified TB cases during the year 2017 - 2020 under NTEP of Bengaluru city. Socio - demographic data, clinical characteristics and diagnostic data were studied. Data analysis was conducted in Python (version 3.9.4) to ascertain the treatment outcomes and its trend in the study area. Results: A total of 689 patients were identified as DR TB cases having resistance to any first line anti TB drug during the year 2017 - 2020 . The mean age of the DR TB patients was observed as 36.7 years (95% CI: 22.3 - 51.1). Among them 434(63.0%) were male, 254(36.9%) were female and 01(0.1%) were transgender. The study revealed the favourable treatment outcomes of 56.6% among the overall DR T B patients and 42.2% among the MDR RR TB patients in Bengaluru city. Conclusion: The study depicted trends of improvements in the successful treatment outcomes among overall DR TB patients from the year 2017 to 2020, but on the other hand the same among th e MDR RR TB patients is a cause of concern. The study highlights adopting a multipronged scheme focusing on End TB strategy by improving diagnostic capability, assuring high - quality treatment and averting drug resistance propagation among